RNAi-mediated silencing of the Bmi-1 gene causes growth inhibition and enhances doxorubicin-induced apoptosis in MCF-7 cells
2009

Silencing the Bmi-1 Gene Reduces Growth and Increases Apoptosis in Breast Cancer Cells

publication Evidence: moderate

Author Information

Author(s): Wu Xiang-mei, Liu Xing, Bu You-quan, Sengupta Joyeeta, Cui Hong-juan, Yi Fa-ping, Liu Tao, Yuan Chen-fu, Shi Yan-yan, Song Fang-zhou

Primary Institution: Chongqing Medical University

Hypothesis

Can silencing the Bmi-1 gene enhance the sensitivity of MCF-7 breast cancer cells to doxorubicin?

Conclusion

Silencing the Bmi-1 gene inhibits the growth of MCF-7 cells and increases their sensitivity to doxorubicin-induced apoptosis.

Supporting Evidence

  • Silencing Bmi-1 led to a 67% reduction in mRNA levels and a 70% reduction in protein levels.
  • Bmi-1 silencing resulted in a significant increase in the number of cells in the G0/G1 phase of the cell cycle.
  • MCF-7 cells with silenced Bmi-1 showed a higher apoptotic rate when treated with doxorubicin compared to controls.
  • The IC50 value of doxorubicin was significantly lower in Bmi-1 silenced cells than in control cells.

Takeaway

When scientists turned off a gene called Bmi-1 in breast cancer cells, the cells grew slower and were more easily killed by a cancer medicine.

Methodology

The study used RNA interference to silence the Bmi-1 gene in MCF-7 cells and assessed cell growth, apoptosis, and chemosensitivity to doxorubicin.

Limitations

The study was conducted in vitro, and results may not fully translate to in vivo conditions.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1590/S1415-47572009005000092

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication